CervoMed’s ex-Vertex drug has failed to reduce the severity of patients’ dementia in a phase 2 trial, halting plans for a ...
There remains an art as much as a science to the use of these drugs. The science behind ACE inhibitor use is well accepted, the art, however, is a work in progress, with many subtleties to use ...
An emerging class of anticancer drugs called EZH2 inhibitors may greatly enhance the potency of some cancer immunotherapies, ...
An emerging class of anticancer drugs called EZH2 inhibitors may greatly enhance the potency of some cancer immunotherapies, ...
Edward Scolnick led the development of dozens of medicines while at Merck. His current mission pits him against time and the ...
The brain cells, or neurons, also showed signs of recovery, the scientists reported in Nature Neuroscience. This discovery ...
Researchers have introduced a proof-of-concept for a new class of antivirals that could be used against RNA viruses including ...
A study in mice offers evidence that inhibiting EZH2 can enhance lymphoma immunogenicity and overcome CAR-T cell therapy resistance.
A new method can improve treatment for patients with chronic myeloid leukemia by predicting which medication will be most ...
Consuming too much added sugar can increase the risk of chronic diseases such as Type 2 diabetes, heart disease, obesity, non-alcoholic fatty liver disease, high blood pressure and some cancers, ...
University of Michigan researchers identified UBA1 as a key player in immunotherapy resistance. Inhibiting UBA1 boosts T-cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback